Published in Health Insurance Law Weekly, July 2nd, 2006
Study 1: Botulinum A toxin injected into the gastric wall was a safe treatment option for class III obesity.
"Obesity represents a major public health problem in western countries. Initial studies suggest that injection of botulinum A toxin (Btx-A) into the antropyloric region inhibits propulsive contractions of the antral pump, with delay in gastric emptying, early satiety and weight loss," investigators in Brazil report.
A. Cardoso and colleagues working with the Federal University of Minas Gerais explained, "After approval by the University...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Insurance Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.